Magnesium And Verapamil After Recanalization in Ischemia of the Cerebrum: a Clinical and Translational Study. "MAVARIC"

Recruiting

Phase 1 Results N/A

Summary of Purpose

This is a phase 1, blinded-outcome, randomized, placebo controlled study to investigate the safety and feasibility of super-selective intra-arterial administration of verapamil and magnesium sulfate immediately following successful endovascular thrombectomy as a potential neuroprotective synergistic therapeutic strategy in emergent large vessel occlusion stroke. This trial represents the first time that magnesium...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 October 2017.

11 Oct 2017 21 Sep 2016 1 May 2019 1 May 2019 1 Jun 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment

Contacts